

Science without borders
Imperial hosts landmark UK-Korea symposium on Engineering Biology
Imperial unites global leaders to drive innovation, collaboration, and real-world impact in Engineering Biology.
Imperial hosts landmark UK-Korea symposium on Engineering Biology
Imperial unites global leaders to drive innovation, collaboration, and real-world impact in Engineering Biology.
Tackling childhood asthma: How early-life conditions shape health inequalities
A new study has shed light on how early-life conditions contribute to social inequalities in childhood asthma across Europe.
Study reveals cellular energy crisis in Parkinson's disease
The molecular interaction could reveal why some brain cells are more vulnerable than others in Parkinson’s disease.
Poor backgrounds can leave a lifelong accelerated ageing marker in children
Economic disadvantage leaves a biological imprint on children which could last throughout their lifetime, reducing their quality and length of life.
Six Imperial professors elected Fellows of the Academy of Medical Sciences
Imperial scientists from fields including infectious disease, childhood asthma, and public health are among those recognised.
Prof Wiebke Arlt appointed President of the European Society of Endocrinology
Professor Wiebke Arlt has been appointed President of the ESE—becoming the first woman to hold this prestigious role
Microbial Foods as a sustainable, healthy and resilient source of nutrients
Researchers explain the potential of microbial foods as an alternative source of nutrients, showing how this sector could be successful for the UK
New flexible hepatitis C treatment options could help elimination efforts
Shorter or more flexible hepatitis C treatments are just as effective as standard courses, offering more accessible options for patients.
Environmental Research Group receive gold award for sustainable lab practices
The Environmental Research Group has received a Gold LEAF award for improving the sustainability and efficiency of their lab work.
Prof Chris Gale appointed as Deputy Director, Imperial Clinical Trials Unit
We are delighted to welcome Professor Chris Gale as the new Deputy Director of Imperial Clinical Trials Unit (ICTU).